0001410939-22-000008.txt : 20220217 0001410939-22-000008.hdr.sgml : 20220217 20220217160327 ACCESSION NUMBER: 0001410939-22-000008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220215 FILED AS OF DATE: 20220217 DATE AS OF CHANGE: 20220217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Westby Keith CENTRAL INDEX KEY: 0001696429 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36080 FILM NUMBER: 22648009 MAIL ADDRESS: STREET 1: ONE UNIVERSITY SQUARE DRIVE, SUITE 280 CITY: PRINCETON STATE: NJ ZIP: 08540 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IVERIC bio, Inc. CENTRAL INDEX KEY: 0001410939 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208185347 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 BUSINESS PHONE: (609) 474-6755 MAIL ADDRESS: STREET 1: 8 SYLVAN WAY CITY: PARSIPPANY STATE: NJ ZIP: 07054 FORMER COMPANY: FORMER CONFORMED NAME: Ophthotech Corp. DATE OF NAME CHANGE: 20070828 4 1 wf-form4_164513178396208.xml FORM 4 X0306 4 2022-02-15 0 0001410939 IVERIC bio, Inc. ISEE 0001696429 Westby Keith C/O IVERIC BIO, INC. 8 SYLVAN WAY PARSIPPANY NJ 07054 0 1 0 0 SVP & COO Common Stock 2022-02-15 4 S 0 10000 15.1634 D 108280 D The sale reported on this form was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 16, 2021. The sale price of the Reporting Person's shares represents the weighted average price of all shares sold by a broker in multiple transactions effected at prices ranging from $15.0000 to $15.3200 per share on February 15, 2022. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Registrant or a security holder of the Registrant, information regarding the number of shares sold at each price within the range. /s/ Todd Anderman, as attorney-in-fact for Keith Westby 2022-02-16